Latest news
ANI Pharma investor presentation spotlights Rare Disease shift, targets 2026 net revenue of $1.1 billion - BitgetBitget · Fri, 07 Aug 2026 11:36:24 GMTANI Pharmaceuticals Reports Second-Quarter 2026 Results, Raises Cortrophin Gel Guidance and Reaffirms Full-Year Outlook - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 11:00:00 GMTANI Pharmaceuticals rated Buy at $80, with grow... - PluangPluang · Thu, 06 Aug 2026 07:00:00 GMT